SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,596 | +1795.5% | 87,413 | +2056.7% | 0.10% | +1920.0% |
Q1 2023 | $559 | -97.3% | 4,053 | -97.4% | 0.01% | -98.3% |
Q4 2022 | $20,347 | -99.3% | 157,025 | +470.8% | 0.30% | +637.5% |
Q3 2022 | $3,041,000 | -61.6% | 27,510 | -74.0% | 0.04% | -58.8% |
Q2 2022 | $7,922,000 | +606.1% | 105,687 | +635.6% | 0.10% | +592.9% |
Q1 2022 | $1,122,000 | -20.0% | 14,368 | -7.7% | 0.01% | -6.7% |
Q4 2021 | $1,402,000 | +21.4% | 15,564 | +4.7% | 0.02% | +15.4% |
Q2 2021 | $1,155,000 | -57.5% | 14,862 | -59.3% | 0.01% | -67.5% |
Q1 2021 | $2,719,000 | +1052.1% | 36,488 | +1414.7% | 0.04% | +207.7% |
Q1 2020 | $236,000 | -71.8% | 2,409 | -62.8% | 0.01% | -18.8% |
Q4 2019 | $836,000 | – | 6,476 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |